ACTA has a cooling and heating device which is highly efficient, uses no toxic chemicals, has no moving parts and will operate for decades with little or no maintenance.
A medical device company that was founded to solve an unsafe and complicated problem of filtering. CarrTech has built and patented and submitted to the FDA the first and only integrated all in one package, one- needle, one-step filter pioneering a safer, more efficient, and cost-effective way to preparing ampoule-based medications.
Our Freeze-on-Demand machine and pod technology is revolutionizing the way premium ice cream and frozen beverages are produced, transported,and enjoyed around the world.
Reaching for the “holy grail” of oral biologics with a first-in-class modality intended for gastrointestinal (GI)-related diseases including gut-health axis disorders.
i-Lumen Scientific™ is a retinal biotech company, pioneering a new field in ophthalmics, designed to improve eyesight in patients whose vision has been impaired by nonexudative (dry) age-related macular degeneration (dAMD).
IMEROPEX™ provides clients a platform for experiencing and resolving crises in an alternate virtual reality to prevent or limit their occurrence in the real world.
Natáur's fermentation-based platform provides a cost-competitive, environmentally friendly alternative to the traditional petroleum supply chain for sulfur ingredients.
NeuroEM's first-of-its-kind device offers a safe, effective, and non-invasive approach to treating neurodegenerative diseases, including Alzheimer's, and protecting brain health throughout the aging process.
At Novel Microdevices, we are revolutionizing diagnostics with our Next-Gen, Patent-Protected Point-of-Care PCR Platform, delivering lab accuracy, rapid results, and unmatched affordability.
Peak 15 Capital invests directly and alongside trusted local operators through strategic partnerships across a diverse U.S. commercial real estate spectrum, including multifamily, industrial, office, and retail assets.
PredxBio is powering next-generation cancer therapeutics with AI-driven spatial biomarkers that delves into the mechanism of action of drugs and predicts the patient outcomes with over 90% accuracy.
Propel IOT provides small and medium businesses (SMBs) with enterprise-grade real time asset management for mobile and movable assets through affordable AI-powered IOT solutions
The world’s first Travel Risk Tech platform, combining real-time threat intelligence, proactive safety features, and comprehensive insurance solutions to redefine global travel risk management.
A Social Finance and AI-driven Education Technology platform transforming how investors discover, engage, learn, and invest more consistently with a dynamic and collaborative approach.
Tympanogen develops ear, nose, and throat (ENT) devices that simplify existing
procedures and improve treatment outcomes using our proprietary gel technology.
